A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy)

Vaccine. 2019 Sep 16;37(39):5812-5816. doi: 10.1016/j.vaccine.2019.08.014. Epub 2019 Aug 16.

Abstract

Influenza season started in Italy during the month of October 2018, approaching the epidemic peak in January 2019. This report aim to explore the mid-term virologic surveillance data of the 2018-2019 influenza season in Sicily and to estimate the effectiveness of seasonal influenza vaccine (VE) against A(H1N1)pdm09 and A(H3N2) influenza viruses. A test-negative design was used to evaluate influenza VE. In Sicily, almost all influenza infections were sustained by influenza type A viruses, of which 62.3% were A(H3N2) and 36.3% A(H1N1)pdm09. A reduction of laboratory confirmed influenza cases in Sicilian population immunized against influenza were observed. In particular, an overall significant protective values were observed for any influenza A viruses (Adj-VE = 44.0%; 95%CI: 11.2-64.7%), especially among 15-64 years old age group (Adj-VE = 59.5%; 95%CI: 0.03-83.1) and among the elderly (Adj-VE = 73.6%; 95% CI: 29.4-90.2).

Keywords: Influenza epidemic; Influenza vaccine effectiveness; Influenza viruses; Laboratory confirmed cases; Surveillance network; Test-negative design.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Immunization / methods
  • Infant
  • Influenza A Virus, H1N1 Subtype / immunology*
  • Influenza A Virus, H3N2 Subtype / immunology*
  • Influenza Vaccines / immunology*
  • Influenza, Human / microbiology*
  • Influenza, Human / prevention & control*
  • Male
  • Middle Aged
  • Sicily
  • Vaccination / methods
  • Vaccine Potency
  • Young Adult

Substances

  • Influenza Vaccines